Revenue: The sum of all revenue fields included for a company's operating activities.
Prelude Therapeutics Incorporated (PRLD) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-33.08M |
|
-- |
|
-- |
|
$37.38M |
|
$-37.38M |
|
$4.30M |
|
$-33.08M |
|
$-33.08M |
|
$-33.08M |
|
$-33.08M |
|
$-33.08M |
|
$-33.08M |
|
$-37.38M |
|
$-38.12M |
|
60.36M |
|
60.36M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$235.59M |
|
$7.33M |
|
$42.08M |
|
$277.67M |
|
$21.83M |
|
-- |
|
$18.75M |
|
$40.58M |
|
$237.09M |
|
$237.09M |
|
$237.09M |
|
54.91M |
|
| Cash Flow Statement Financials | |
$-107.06M |
|
$-34.65M |
|
$136.40M |
|
$34.65M |
|
$29.34M |
|
$-5.31M |
|
$25.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-110.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.95% |
|
-13.95% |
|
-11.91% |
|
-13.95% |
|
$4.32 |
|
$-1.83 |
|
$-1.77 |
|